14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of COPN.SW
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Cosmo Pharmaceuticals N.V. stock upgraded to Buy Candidate.
(Updated on May 17, 2024)

Buy or Hold candidate since Mar 27, 2024 Gain 4.29% PDF

The Cosmo Pharmaceuticals N.V. stock price fell by -0.82% on the last day (Friday, 17th May 2024) from 73.50 Fr to 72.90 Fr. During the last trading day the stock fluctuated 0.82% from a day low at 72.80 Fr to a day high of 73.40 Fr. The price has been going up and down for this period, and there has been a 1.82% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -17 thousand shares and in total, 7 thousand shares were bought and sold for approximately 521.16 Fr thousand.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.23% during the next 3 months and, with a 90% probability hold a price between 77.10 Fr and 86.87 Fr at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

COPN.SW Signals & Forecast

The Cosmo Pharmaceuticals N.V. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at 72.21 Fr and 71.21 Fr. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, April 24, 2024, and so far it has fallen -3.19%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Cosmo Pharmaceuticals N.V. stock

Cosmo Pharmaceuticals N.V. finds support from accumulated volume at 69.90 Fr and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved 0.600 Fr between high and low, or 0.82%. For the last week the stock has had daily average volatility of 1.64%

Our recommended stop-loss: 69.82 Fr (-4.22%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 15 days ago.)

Trading Expectations (COPN.SW) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Cosmo Pharmaceuticals N.V. to open at 73.03 Fr, and during the day (based on 14 day Average True Range), to move between 71.30 Fr and 74.50 Fr, which gives a possible trading interval of +/-1.60 Fr (+/-2.19%) up or down from last closing price. If Cosmo Pharmaceuticals N.V. takes out the full calculated possible swing range there will be an estimated 4.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at 73.50 Fr (0.82%) than the support at 69.90 Fr (4.12%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Cosmo Pharmaceuticals N.V. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Cosmo Pharmaceuticals N.V. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 3.172 Buy Candidate Upgraded

Predicted Opening Price for Cosmo Pharmaceuticals N.V. of Tuesday, May 21, 2024

Fair opening price May 21, 2024 Current price
73.03 Fr ( 0.183%) 72.90 Fr

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for COPN.SW

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 73.63 1.01 %
R2 73.40 0.692 %
R1 73.26 0.497 %
Current price: 72.90
Support S1 72.80 -0.132 %
S2 72.66 -0.326 %
S3 72.43 -0.640 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 74.40 2.06 %
R2 73.60 0.96 %
R1 73.50 0.82 %
Current price 72.90
Support S1 69.90 -4.12%
S2 66.50 -8.78%
S3 63.50 -12.89%

COPN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 28, 2024 May 28, 2024 May 28, 2024 0 Fr 0%
2 May 31, 2023 May 31, 2023 Jun 02, 2023 1.05 Fr 2.19%
3 Jun 01, 2022 Jun 01, 2022 Jun 03, 2022 0.95 Fr 1.91%
4 May 31, 2022 May 31, 2022 Jun 03, 2022 0.95 Fr 1.91%
5 Mar 24, 2017 May 29, 2017 May 31, 2017 1.50 Fr 0.92%

FAQ

What is the symbol for Cosmo Pharmaceuticals N.V. Stock and on which exchange is it traded?
The symbol for Cosmo Pharmaceuticals N.V. is COPN.SW and it is traded on the SIX (SIX Swiss Exchange).

Should I buy or sell Cosmo Pharmaceuticals N.V. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Cosmo Pharmaceuticals N.V. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Cosmo Pharmaceuticals N.V. Stock?
Cosmo Pharmaceuticals N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cosmo Pharmaceuticals N.V. Stock.

What's the current price of Cosmo Pharmaceuticals N.V. Stock?
As of the end of day on the May 17, 2024, the price of an Cosmo Pharmaceuticals N.V. (COPN.SW) share was 72.90 Fr.

What is the 52-week high and low for Cosmo Pharmaceuticals N.V. Stock?
The 52-week high for Cosmo Pharmaceuticals N.V. Stock is 76.00 Fr and the 52-week low is 33.70 Fr.

What is the market capitalization of Cosmo Pharmaceuticals N.V. Stock?
As of the May 17, 2024, the market capitalization of Cosmo Pharmaceuticals N.V. is 1.172B.

When is the next earnings date for Cosmo Pharmaceuticals N.V.?
The upcoming earnings date for Cosmo Pharmaceuticals N.V. is Jul 24, 2024.
Click to get the best stock tips daily for free!

About Cosmo Pharmaceuticals N.V.

Cosmo Pharmaceuticals N.V. Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and Methylene Blue MMX, diagnostic drug to enhance ... COPN.SW Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT